Sign in
4

Changes in Ownership

Yarrow Bioscience, Inc. Filed Acc 0001209191-20-018224

President and CEO acquired 191,952 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Domzalski David · President and CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Owned after D/I
2020-03-09 Grant or award : show line 1 in the form +53,850 53,850 D
2020-03-09 Grant or award : show line 2 in the form +138,102 191,952 D

Table II: Derivative

8 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2020-03-09 Grant or award : show line 3 in the form Stock Options +11,107 $13.48 2024-06-09 11,107 11,107 D
2020-03-09 Grant or award : show line 4 in the form Stock Options +140,286 $12.06 2025-11-10 140,286 140,286 D
2020-03-09 Grant or award : show line 5 in the form Stock Options +35,544 $10.20 2026-03-01 35,544 35,544 D
2020-03-09 Grant or award : show line 6 in the form Stock Options +42,278 $17.25 2027-01-01 42,278 42,278 D
2020-03-09 Grant or award : show line 7 in the form Stock Options +194,141 $9.73 2027-08-08 194,141 194,141 D
2020-03-09 Grant or award : show line 8 in the form Stock Options +41,578 $8.55 2028-02-27 41,578 41,578 D
2020-03-09 Grant or award : show line 9 in the form Stock Options +101,296 $6.37 2029-01-01 101,296 101,296 D
2020-03-09 Grant or award : show line 10 in the form Stock Options +142,716 $6.81 2030-02-24 142,716 142,716 D
Loading xslF345X03/doc4.xml…